Surviving cancer is often seen as a slim chance, you never know who may be affected by this disease and whether they would live to see the end of their treatment. However, bleak the odds may be, Linda ...

Paul B. Renz, DO, discussed the ideal uses of MR-LINAC in pancreatic, prostate, liver, head and neck, and rectal cancers.

Pancreatic ductal adenocarcinoma, the most common form of pancreatic cancer and the fourth leading cause of cancer-related death, has a 5-year survival rate of less than 10%.1 The impact of pancreatic ...

Cryptic peptides, which are expressed in pancreatic cancer cells, could be promising targets for T-cell therapies that attack pancreatic tumors, according to a new study.

Researchers from MIT and Dana-Farber Cancer Institute have discovered that a class of peptides expressed in pancreatic cancer ...

The team is exploring whether biomarker testing could also identify patients who benefit more from immune checkpoint inhibitors after radiation.

Researchers from MIT and Dana-Farber Cancer Institute have discovered that a class of peptides expressed in pancreatic cancer ...

Oncosil Medical Ltd.’s brachytherapy device outperformed stereotactic body radiation therapy plus chemotherapy in patients with unresectable or borderline-resectable locally advanced pancreatic cancer ...

The Pancreatic Cancer Action Network Fellowship, funded by the Francois Wallace Monahan Fund, is designed to help advance developing pancreatic cancer research. This Fellowship is available to a ...

Garner was diagnosed with pancreatic cancer in February 2024 and has undergone numerous radiation and chemotherapy treatments. He’ll begin another chemo treatment on Thursday, but not before he ...

Researchers analyzed DNA from pancreatic cancer patients and found that FUT2 and FUT3 genotypes ... initially classified as inoperable (before receiving chemotherapy or radiation treatment). The TMGM ...